Literature DB >> 23066319

Graft-versus-host disease after liver transplantation: a comprehensive literature review.

Sami Akbulut1, Mehmet Yilmaz, Sezai Yilmaz.   

Abstract

AIM: To determine the factors affecting mortality in patients who developed graft-versus-host disease (GvHD) after liver transplantation (LT).
METHODS: We performed a review of studies of GvHD following LT published in the English literature and accessed the PubMed, Medline, EBSCO, EMBASE, and Google Scholar databases. Using relevant search phrases, 88 articles were identified. Of these, 61 articles containing most of the study parameters were considered eligible for the study. Risk factors were first examined using a univariate Kaplan-Meier model, and variables with a significant association (P < 0.05) were then subjected to multivariate analyses using a Cox proportional-hazards model.
RESULTS: The 61 articles reported 87 patients, 58 male and 29 female, mean age, 40.4 ± 15.5 years (range: 8 mo to 74 years), who met the inclusion criteria for the present study. Deaths occurred in 59 (67.8%) patients, whereas 28 (32.2%) survived after a mean follow-up period of 280.8 ± 316.2 d (range: 27-2285 d). Among the most frequent symptoms were rash (94.2%), fever (66.6%), diarrhea (54%), and pancytopenia (54%). The average time period between LT and first symptom onset was 60.6 ± 190.1 d (range: 2-1865 d). The Kaplan-Meier analysis revealed that pancytopenia (42.8% vs. 59.3%, P = 0.03), diarrhea (39.2% vs. 61.0%, P = 0.04), age difference between the recipient and the donor (14.6 ± 3.1 years vs. 22.6 ± 2.7 years, P < 0.0001), and time from first symptom occurrence to diagnosis or treatment (13.3 ± 2.6 mo vs. 15.0 ± 2.3 mo, P < 0.0001) were significant factors affecting mortality, whereas age, sex, presence of rash and fever, use of immunosuppressive agents, acute rejection before GvHD, etiological causes, time of onset, and donor type were not associated with mortality risk. The Cox proportional-hazards model, determined that an age difference between the recipient and donor was an independent risk factor (P = 0.03; hazard ratio, 7.395, 95% confidence interval, 1.2-46.7).
CONCLUSION: This study showed that an age difference between the recipient and donor is an independent risk factor for mortality in patients who develop GvHD after LT.

Entities:  

Keywords:  Age factors; Chimerism; Diarrhea; Graft-versus-host disease; Immunosuppression; Liver transplantation; Pancytopenia; Rash

Mesh:

Substances:

Year:  2012        PMID: 23066319      PMCID: PMC3468857          DOI: 10.3748/wjg.v18.i37.5240

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  68 in total

1.  Graft versus host disease in a liver transplant patient with hepatitis B and hepatocellular carcinoma.

Authors:  H J Merhav; M Landau; A Gat; E Gazit; M Baratz; A Bialy-Golan; F Konikof; S Bril; R Nakache
Journal:  Transplant Proc       Date:  1999-06       Impact factor: 1.066

2.  Detection of circulating donor deoxyribonucleic acid by microsatellite analysis in a liver transplant recipient.

Authors:  M Burt; E Jazwinska; S Lynch; P Kerlin; D Gill; C Steadman; J Jonsson; R Strong; E Powell
Journal:  Liver Transpl Surg       Date:  1996-09

3.  Successful treatment of graft-vs-host disease after a second liver transplant.

Authors:  H Aziz; P Trigo; J Lendoire; G Bianco; J Saúl; G Braslavsky; M Kien; M Zylberman; G Cueto; O Imventarza
Journal:  Transplant Proc       Date:  1998-09       Impact factor: 1.066

4.  Successful resolution of severe graft versus host disease after liver transplantation correlating with disappearance of donor DNA from the peripheral blood.

Authors:  G Paizis; B D Tait; P Kyle; P W Angus; A P Grigg
Journal:  Aust N Z J Med       Date:  1998-12

Review 5.  Severe graft versus host disease following liver transplantation confirmed by PCR-HLA-B sequencing: report of a case and literature review.

Authors:  J A Sanchez-Izquierdo; C Lumbreras; F Colina; J Martinez-Laso; C Jiménez; R Gómez; I García; M Alvarez; A Arnaiz-Villena; E Moreno
Journal:  Hepatogastroenterology       Date:  1996 Jul-Aug

6.  Survival of graft-versus-host disease in a liver transplant recipient.

Authors:  M S Cattral; A N Langnas; J L Wisecarver; J C Harper; R J Rubocki; J S Bynon; I J Fox; T G Heffron; B W Shaw
Journal:  Transplantation       Date:  1994-04-27       Impact factor: 4.939

7.  Fatal graft-versus-host-disease: a grave complication after orthotopic liver transplantation.

Authors:  U P Neumann; U Kaisers; J M Langrehr; A R Müller; G Blumhardt; W O Bechstein; H Lobeck; H Riess; R Zimmermann; P Neuhaus
Journal:  Transplant Proc       Date:  1994-12       Impact factor: 1.066

8.  Unusual presentation of graft-versus-host disease in pediatric liver transplant recipients: evidence of late and recurrent disease.

Authors:  A D Pinna; D Weppler; M Berho; M Masetti; W DeFaria; T Kato; J Thompson; C Ricordi; A G Tzakis
Journal:  Pediatr Transplant       Date:  1999-08

9.  Complete lymphoid chimerism and chronic graft-versus-host disease in an infant recipient of a hepatic allograft from an HLA-homozygous parental living donor.

Authors:  P F Whitington; C M Rubin; E M Alonso; T W McKeithan; J Anastasi; J Hart; J R Thistlethwaite
Journal:  Transplantation       Date:  1996-11-27       Impact factor: 4.939

10.  One-way donor-recipient HLA-matching as a risk factor for graft-versus-host disease in living-related liver transplantation.

Authors:  T Kiuchi; H Harada; H Matsukawa; M Kasahara; Y Inomata; S Uemoto; K Asonuma; H Egawa; E Maruya; H Saji; K Tanaka
Journal:  Transpl Int       Date:  1998       Impact factor: 3.782

View more
  9 in total

1.  Graft versus host disease after liver transplantation following radiotherapy for the treatment of hepatocellular carcinoma: A case report and literature review.

Authors:  Zijun Chen; Chuangye Han; Xiangkun Wang; Yongfei He; Tianyi Liang; Shutian Mo; Xuan Li; Guangzhi Zhu; Hao Su; Xinping Ye; Zili Lv; Liming Shang; Zhang Wen; Minhao Peng; Tao Peng
Journal:  SAGE Open Med Case Rep       Date:  2022-05-24

2.  Graft versus host disease after liver transplantation: A case report.

Authors:  Sencan Acar; Mutlu Arat; Tulay Tecimer; Kamil Yalcin Polat; Murat Akyildiz
Journal:  Hepatol Forum       Date:  2022-01-10

Review 3.  Immunological basis for treatment of graft versus host disease after liver transplant.

Authors:  Vikrant Rai; Nicholas Edward Dietz; Devendra K Agrawal
Journal:  Expert Rev Clin Immunol       Date:  2016-02-24       Impact factor: 4.473

4.  Macrochimerism in Intestinal Transplantation: Association With Lower Rejection Rates and Multivisceral Transplants, Without GVHD.

Authors:  J Zuber; S Rosen; B Shonts; B Sprangers; T M Savage; S Richman; S Yang; S P Lau; S DeWolf; D Farber; G Vlad; E Zorn; W Wong; J Emond; B Levin; M Martinez; T Kato; M Sykes
Journal:  Am J Transplant       Date:  2015-05-18       Impact factor: 8.086

Review 5.  Modeling human gastrointestinal inflammatory diseases using microphysiological culture systems.

Authors:  Kira G Hartman; James D Bortner; Gary W Falk; Gregory G Ginsberg; Nirag Jhala; Jian Yu; Martín G Martín; Anil K Rustgi; John P Lynch
Journal:  Exp Biol Med (Maywood)       Date:  2014-04-29

6.  Fever and Pancytopenia in a Liver Transplant Recipient: Going Against the Rules of Occam's Razor.

Authors:  Lionel Hon Wai Lum; Fei Wen Chen; Louise Jackett; Simone I Strasser; Rebecca J Davis
Journal:  Transplant Direct       Date:  2017-06-06

7.  Case Report: Liver as a Source of Hematopoietic Stem Cells After Liver Transplantation Following Hematopoietic Stem Cell Transplantation.

Authors:  Tomasz Jarmoliński; Monika Rosa; Blanka Rybka; Renata Ryczan-Krawczyk; Kornelia Gajek; Katarzyna Bogunia-Kubik; Maja Klaudel-Dreszler; Piotr Czubkowski; Piotr Kaliciński; Joanna Teisseyre; Marek Stefanowicz; Ewa Gorczyńska; Krzysztof Kałwak; Marek Ussowicz
Journal:  Front Pediatr       Date:  2022-03-23       Impact factor: 3.418

8.  Graft-versus-host disease, a rare complication after orthotopic liver transplantation.

Authors:  Andrew Ofosu; Andrew Zabolotsky; Miguel Rufail; Joseph Spataro; Jesse Civan
Journal:  Clin Case Rep       Date:  2017-12-07

Review 9.  Dermatological Disorders following Liver Transplantation: An Update.

Authors:  Dipesh Kumar Yadav; Xue Li Bai; Tingbo Liang
Journal:  Can J Gastroenterol Hepatol       Date:  2019-04-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.